Human Milk And Infant’s Developing Immune System
Human milk is the ideal nutritional source for all newborns1. In addition to the macro- and micronutrients, it contains many distinct bioactive molecules that have shown beneficial effects on the development of gastrointestinal, immune, and brain systems2. Thus, breast milk is considered as the best biological fluid for optimum growth and development of infants2. This article reviews the beneficial effects of human milk bioactive molecules such as oligosaccharide on the gut and immune health of infants.
Human breast milk is composed of approximately 1.0% protein, 3.8% fat, 7.0% lactose, and 87% of water2. It also contains various bioactive molecules such as growth factors, cytokines, hormones, antimicrobial factors, etc. that impacts infant immunity, and provides protection against allergic reactions and chronic diseases3. Oligosaccharides found in human milk are one such group of bioactive molecules that are synthesized from lactose in the mammary gland1. They are the third-major constituent of the maternal milk after lactose and lipids, hence, are recognized as a key element3. They possess prebiotic, anti-inflammatory, glycome-modifying and anti-adhesive and play a significant role in the development of gut microbiota and maintenance of immune health of infants.2,4
Structural aspects of human milk oligosaccharides (HMOs)
Human milk contains a wide variety of oligosaccharides that differ in their amount and composition among individuals5. About 200 structures of oligosaccharides have been identified3. These oligosaccharides are primarily made up of five major building blocks that include D-galactose (Gal), D-glucose (Glc), sialic acid (Sia), L-fucose (Fuc), and N-acetylglucosamine (GlcNAc). They contain lactose at their reducing end which can be extended by galactosylation and/or by N-acetylglucosaminylation with or without fucosylation and/or sialylation6. Besides lactose, ≥15 linear or branched neutral oligosaccharides have also been recognized as core structures of other HMOs3,6. Based on their abundance, HMOs are divided into three categories:3
- Acidic sialylated HMOs3
- Neutral non-fucosylated HMOs3
- Neutral fucosylated HMOs3
Figure 1: Basic structure of HMOs. Core structures of HMOs can be further extended linearly by adding additional Gal-GlcNAc building blocks to terminal Galactoses via β1-3 glycosidic linkages or via β1-6 glycosidic linkages (Adapted from Ayechu-Muruzabal et al. 2018)7.
Impact of oligosaccharides on gut and immune health
HMOs are indigestible and reach the colon intact where they act as a nutritional source for the bacteria present in the intestinal flora. Besides their ‘prebiotic effect’ (enhancing the growth of favorable bacteria), they also have several other benefits for the host3, which are summarized below:
Figure 2: Postulated benefits of HMOs. (A)HMOs are prebiotics that promotes the growth of beneficial bacteria (green) and suppress the growth of potential pathogen (blue). (B) HMOs are antimicrobials that protect pathogen attachment to the intestinal epithelial cell surface. (C) HMOs directly modulate intestinal epithelial cell gene expression which leads to the changes in cell responses. (D) HMOs alter lymphocyte cytokine production, potentially leading to a balanced Th1/Th2 response. (E) HMOs, provide nutrients for brain development (Adapted from Bode et al. 2012).8
Antimicrobials and Antivirals: Prebiotic oligosaccharides in breast milk prevent infections in newborns by mimicking the glycan structures present on the surface receptors of the gut epithelium and reduce the binding of pathogens on these receptors for colonization.6 They may also act as inhibitors for the toxins released by bacteria. Both neutral and acidic oligosaccharides have shown anti-infective properties in infants. 6,7
Intestinal epithelial cell modulator: Evidence suggests that prebiotic oligosaccharides promote gut maturation via interacting with glycans present on the epithelial or dendritic cell surface. They also contribute to the barrier integrity by increasing the growth of Bifidobacterium.6,7 A study conducted to find a link between levels of 2-linked fucosyloligosaccharides (FOS) in breast milk and moderate-to-severe diarrhea demonstrated that the incidence of diarrhea in infants was inversely related to levels of FOS.3 Moreover, some oligosaccharides can also reduce the risk of a fatal intestinal disorder, necrotizing enterocolitis (NEC) in preterm infants.6
Prebiotics: Oligosaccharides are a source of carbon and energy that is mostly utilized by the probiotic, Bifidobacterium. Reportedly, this bacterium metabolizes the oligosaccharides more efficiently than other bacterial species. For example, Bifidobacteria showed strong growth on culture containing fucosylated oligosaccharides while the growth of E. coli and Clostridium perfringens were suppressed with the same culture. They, thus promote the growth of Bifidobacterium which has several benefits:6,7
- Production of lactic acid and short-chain fatty acid which helps reduce pH of the gut and prevent the growth of pathogens.
- Bifidobacteria compete well with other pathogens for limited nutrients due to their abundance in the gut.
- They prevent the binding of other pathogens by occupying the maximum epithelial binding sites.
- They also release anti-microbial substances that produce a hostile environment for pathogens.
Immunomodulators: HMOs have numerous immunomodulatory functions that influence infant health. Various studies have reported the presence of prebiotic oligosaccharides such as within systemic circulation and intestine of breastfed infants. They target toll-like receptors (TLRs) that are involved in the recognition of microbes and subsequent modulation of the immune response.7 For example, they decrease the LPS-TLR 4 dependent activation of cytokine IL-8 via reduction of CD14 expression and subsequent inhibition of mucosal inflammation 3. Moreover, they also maintain a balance between Th1/Th2 lymphocyte. Thus, HMOs may play a role in the development of a balanced and efficient immune response that leads to the lesser risk of infections.7
Nutrient providers for the brain: Few oligosaccharides, especially sialylated ones, may be involved in the synthesis of sialic acid-containing glycoprotein and glycolipids (gangliosides) for the development of cognitive ability and brain in infants.6
Mother’s own milk is a well-known food for infants as it provides all essential nutrients and protects against infections.5,7It contains ample amount of prebiotic oligosaccharides, an unconjugated glycans, that not only act as “bifidus factor” to support the colonization of gut microbiota but also prevent the invasion of pathogens and risk of infections.3,8 Moreover, it may also inhibit the expression of an inflammatory gene and modulate immune cell responses.3,8 Owing to the beneficial effects of these oligosaccharides on the gut and immune system, they are recognized as one of the most important elements of human milk for infants’ health.
- Akkerman R, Faas MM, de Vos P. Non-digestible carbohydrates in infant formula as a substitution for human milk oligosaccharide functions: Effects on microbiota and gut maturation. Critical reviews in food science and nutrition. 2019 May 15;59(9):1486-97.
- Martin C, Ling PR, Blackburn G. Review of infant feeding: key features of breast milk and infant formula. Nutrients. 2016;8(5):279.
- Plaza-Díaz J, Fontana L, Gil A. Human milk oligosaccharides and immune system development. Nutrients. 2018 Aug;10(8):1038.
- Thurl S, Munzert M, Henker J, Boehm G, Müller-Werner B, Jelinek J, Stahl B. Variation of human milk oligosaccharides in relation to milk groups and lactational periods. British Journal of Nutrition. 2010 Nov;104(9):1261-71.
- Boehm G, Moro G. Structural and functional aspects of prebiotics used in infant nutrition. The Journal of nutrition. 2008 Sep 1;138(9):1818S-28S.
- Chen X. Human milk oligosaccharides (HMOs): structure, function, and enzyme-catalyzed synthesis. In advance in carbohydrate chemistry and biochemistry 2015 Jan 1 (Vol. 72, pp. 113-190). Academic Press.
- Ayechu-Muruzabal V, van Stigt AH, Mank M, Willemsen LE, Stahl B, Garssen J, Van't Land B. Diversity of human milk oligosaccharides and effects on early life immune development. Frontiers in pediatrics. 2018;6.
- Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology. 2012 Sep 1;22(9):1147-62.